JPM, Day 3: AbbVie duo's $20B ambitions, GSK and Pfizer's what-next moment and Amarin's clear runway

16th January 2020 Uncategorised 0

We’re not gonna lie—Wednesdays at the J.P. Morgan Healthcare Conference feel a bit anticlimactic. But that doesn’t mean the action has stopped. We picked up some unprecedented talk from AbbVie CEO Rick Gonzalez first thing Wednesday morning, and by day’s end had heard some even bigger numbers from a GlaxoSmithKline vaccines exec.

More: JPM, Day 3: AbbVie duo's B ambitions, GSK and Pfizer's what-next moment and Amarin's clear runway
Source: fierce